Search research articles
Contact Us
Filters
Showing results (571-580 of 643) with videos related to
Page
of 65
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 5, 2021
Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics
E Petersen, P Schlagenhauf, S S Lee, et al.
Journal of Medicinal Chemistry
|
August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa
E Verner, B A Katz, J R Spencer, et al.
Nature Communications
|
October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Janice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 24, 2013
High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections
N Lee, G C Y Lui, K T Wong, et al.
Nature Communications
|
November 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
Ka Chun Chong, Yuchen Wei, Carlos King Ho Wong, et al.
The Journal of Infection
|
May 28, 2023
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Rita W Y Ng, Ryan K H Sze, Ka Chun Chong, et al.
Respirology (Carlton, Vic.)
|
October 13, 2009
Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia
Grace Lui, Margaret Ip, Nelson Lee, et al.
Thorax
|
June 5, 2010
Outcomes of adults hospitalised with severe influenza
N Lee, K W Choi, P K S Chan, et al.
Nature Communications
|
January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infections
Eric H Y Lau, Owen T Y Tsang, David S C Hui, et al.
BMC Medicine
|
March 18, 2026
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study
Zihao Guo, Yuchen Wei, Aimin Yang, et al.
Page
of 65
Search research articles
Search
Showing results (571-580 of 643) with videos related to
Sort By:
Page
of 65
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 5, 2021
Mandatory immunization against SARS-CoV-2 of athletes, companions and supporters for the Tokyo Olympics
E Petersen, P Schlagenhauf, S S Lee, et al.
Journal of Medicinal Chemistry
|
August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa
E Verner, B A Katz, J R Spencer, et al.
Nature Communications
|
October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
Janice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 24, 2013
High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections
N Lee, G C Y Lui, K T Wong, et al.
Nature Communications
|
November 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study
Ka Chun Chong, Yuchen Wei, Carlos King Ho Wong, et al.
The Journal of Infection
|
May 28, 2023
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong population
Rita W Y Ng, Ryan K H Sze, Ka Chun Chong, et al.
Respirology (Carlton, Vic.)
|
October 13, 2009
Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia
Grace Lui, Margaret Ip, Nelson Lee, et al.
Thorax
|
June 5, 2010
Outcomes of adults hospitalised with severe influenza
N Lee, K W Choi, P K S Chan, et al.
Nature Communications
|
January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infections
Eric H Y Lau, Owen T Y Tsang, David S C Hui, et al.
BMC Medicine
|
March 18, 2026
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study
Zihao Guo, Yuchen Wei, Aimin Yang, et al.
Page
of 65